Jane Street
RCUS icon

Jane Street’s Arcus Biosciences RCUS Stock Holding History

Jane Street’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,600
Closed -$229K – 12860
2026
Q1 		$229K Sell
10,600
-10,900
-51% -$235K ﹤0.01% 9835
2025
Q4 		$512K Buy
21,500
+600
+3% +$12.2K ﹤0.01% 7632
2025
Q3 		$284K Buy
20,900
+1,700
+9% +$17.7K ﹤0.01% 9010
2025
Q2 		$156K Buy
+19,200
New +$164K ﹤0.01% 8718
2024
Q1 		– Sell
-30,200
Closed -$577K – 9926
2023
Q4 		$577K Sell
30,200
-5,000
-14% -$79.9K ﹤0.01% 6521
2023
Q3 		$632K Sell
35,200
-200
-0.6% -$4.02K ﹤0.01% 5908
2023
Q2 		$719K Buy
+35,400
New +$674K ﹤0.01% 5749
2022
Q4 		– Sell
-41,400
Closed -$1.08M – 9963
2022
Q3 		$1.08M Sell
41,400
-131,100
-76% -$3.47M ﹤0.01% 5275
2022
Q2 		$4.37M Buy
+172,500
New +$4.22M ﹤0.01% 2874
2022
Q1 		– Sell
-5,000
Closed -$202K – 10907
2021
Q4 		$202K Buy
+5,000
New +$194K ﹤0.01% 8808

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Jane Street's RCUS Position: Q2 2026 in Review

Jane Street sold out of Arcus Biosciences (RCUS) in Q2 2026, closing a stake of 107,979 shares — an estimated $2.67M sold.

Jane Street first reported a position in RCUS in Q4 2018 and held it in 23 quarters. The position peaked at $6.33M in Q4 2023. 232 funds tracked by Wall St. Rank hold RCUS as of Q2 2026.

  • Jane Street reported no remaining Arcus Biosciences position as of Q2 2026 after selling out during the quarter.
  • Jane Street sold 107,979 Arcus Biosciences shares in Q2 2026, an estimated $2.67M.
  • Jane Street first reported a position in Arcus Biosciences in Q4 2018 and held it in 23 quarters.
  • Jane Street's Arcus Biosciences position peaked at $6.33M in Q4 2023.
  • 232 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.